Qiagen Corporation, a leading global provider of sample and assay technologies, is headquartered in the United States. Founded in 1984, Qiagen has established itself as a key player in the biotechnology and molecular diagnostics industries, with significant operations across Europe, Asia, and the Americas. The company offers a diverse range of products and services, including nucleic acid extraction, PCR, and next-generation sequencing solutions, which are distinguished by their reliability and efficiency. Qiagen's innovative technologies empower researchers and clinicians to unlock valuable insights from biological samples, enhancing the fields of genomics, personalised medicine, and infectious disease testing. With a strong market position, Qiagen has achieved numerous milestones, including strategic acquisitions and partnerships that have expanded its product portfolio and global reach. The company continues to drive advancements in molecular biology, solidifying its reputation as a trusted partner in scientific research and healthcare.
We don't have data for Qiagen Corporation, but we can show you information about their parent organization instead.
View parent company